Scotoma Perimetry Oculomotor Training

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jul 12, 2022

Keywords

ClinConnect Summary

This clinical trial, called Scotoma Perimetry Oculomotor Training, is studying new ways to help people with severe vision loss due to conditions like macular degeneration. The goal is to understand how the brain can adapt after losing central vision, which could lead to better treatment options for those affected. This research is particularly important for older adults, as many experience declines in vision that affect their daily lives.

If you or a loved one is between the ages of 65 and 74 and has significantly impaired vision (20/100 or worse) from macular degeneration for at least two years, you might be eligible to participate. Participants will undergo training sessions that focus on improving visual function. However, it's important to know that individuals who have difficulty sitting still for long periods or have very large areas of vision loss may not qualify. This trial could offer valuable insights into improving sight for many people experiencing low vision challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Severely impaired vision in both eyes (20/100 or worse)
• • Diagnosis of Macular Degeneration
• • Light sensitivity in the macular retina that is at least 10 dB units worse than in peripheral regions, as demonstrated by a scanning laser ophthalmoscope (SLO, MAIA)
• • Medical record review indicates this disease severity level has been present for at least 2 years.
• Exclusion Criteria:
• • Inability to sit still in eye tracker for extended periods
• • Inability to visualize iris on video eye tracker
• • Bilateral retinal scotomas larger than 20° diameter